Effects of thermal water inhalation in chronic upper respiratory tract infections in elderly and young patients

Immunity and Ageing

Volumn 13, Issue 1, 2016, Pages

  Magrone, Thea ^a   Galantino, Mauro ^b   Di Bitonto, Nunzio ^b   Borraccino, Luisella ^b   Chiaromonte, Gerardo ^b   Jirillo, Emilio ^a  

^a UNIVERSITY OF BARI   (Italy)

^b ASL   (Italy)

Author keywords

Ageing; Chronic upper respiratory tract infections; Cytokines; Thermal water inhalation

Indexed keywords

BROMIDE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; IODINE; SODIUM CHLORIDE; THERMAL WATER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; TH1 CELL; TH17 CELL; TH2 CELL; UPPER RESPIRATORY TRACT INFECTION;

EID: 84970973790     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/s12979-016-0073-0     Document Type: Article

References (57)

1. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122 Suppl 2:1-84.
2. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108 Suppl 5:147-334.
3. Sande MA, Gwaltney JM. Acute community-acquired bacterial sinusitis: continuing challenges and current management. Clin Infect Dis. 2004;39 Suppl 3:151-8.
4. Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol. 2009;124:428-33.
5. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. 2009;30:325-33.
6. Candore G, Caruso C, Jirillo E, Magrone T, Vasto S. Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Curr Pharm Des. 2010;16:584-96.
7. Magrone T, Jirillo E. Disorders of innate immunity in human ageing and effects of nutraceutical administration. Endocr Metab Immune Disord Drug Targets. 2014;14:272-82.
8. MagroneT, Jirillo E. Nutraceuticals in immunosenescence. In: Neves D, editor. Anti-ageing nutrients: evidence-based prevention of age-related diseases. Oxford, UK: Wiley-Blackwell, 2015. p. 183-202. ISBN: 978-1-118-73327-1.
9. Vallejo AN. Immune remodeling: lessons from repertoire alterations during chronological aging immune-mediated disease. Trends Mol Med. 2007;13:94-102.
10. Lang PO, Govind S, Aspinall R. Reversing T cell immunosenescence: why, who, and how. Age (Dordr). 2013;35:609-20.
11. Denkinger MD, Leins H, Schirmbeck R, Florian MC, Geiger H. HSC aging and senescent immune remodeling. Trends Immunol. 2015;36:815-24.
12. Sakata-Kaneko S, Wakatsuki Y, Matsunaga Y, Usui T, Kita T. Altered Th1/Th2 commitment in human CD4+ T cells with ageing. Clin Exp Immunol. 2000;120:267-73.
13. Derhovanessian E, Chen S, Maier AB, Hähnel K, de Craen AJ, Roelofs H, et al. CCR4+ regulatory T cells accumulate in the very elderly and correlate with superior 8-year survival. J Gerontol A Biol Sci Med Sci. 2015;70:917-23.
14. Gibson KL, Wu YC, Barnett Y, Duggan O, Vaughan R, Kondeatis E, et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell. 2009;8:18-25.
15. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69 Suppl 1:4-9.
16. Walter D, Lier A, Geiselhart A, Thalheimer FB, Huntscha S, Sobotta MC, et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature. 2015;520:549-52.
17. Shao L, Feng W, Li H, Gardner D, Luo Y, Wang Y, et al. Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner. Blood. 2014;123:3105-15.
18. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245-70.
19. Murciano C, Yáñez A, O'Connor JE, Gozalbo D, Gil ML. Influence of aging on murine neutrophil and macrophage function against Candida albicans. FEMS Immunol Med Microbiol. 2008;53:214-21.
20. Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, Stromberg AJ, et al. Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol. 2006;79:1314-27.
21. Gomez CR, Karavitis J, Palmer JL, Faunce DE, Ramirez L, Nomellini V, et al. Interleukin-6 contributes to age-related alteration of cytokine production by macrophages. Mediators Inflamm. 2010;2010:475139.
22. Amati L, Marzulli G, Martulli M, Pugliese V, Caruso C, Candore G, et al. Administration of a synbiotic to free-living elderly and evaluation of serum cytokines. A pilot study. Curr Pharm Des. 2010;16:854-8.
23. Amati L, Marzulli G, Martulli M, Tafaro A, Jirillo F, Pugliese V, et al. Donkey and goat milk intake and modulation of the human aged immune response. Curr Pharm Des. 2010;16:864-9.
24. Magrone T, Pugliese V, Fontana S, Jirillo E. Human use of Leucoselect® Phytosome® with special reference to inflammatory-allergic pathologies in frail elderly patients. Curr Pharm Des. 2014;20:1011-9.
25. McLachlan JA, Serkin CD, Morrey KM, Bakouche O. Antitumoral properties of aged human monocytes. J Immunol. 1995;154:832-43.
26. Dace DS, Apte RS. Effect of senescence on macrophage polarization and angiogenesis. Rejuvenation Res. 2008;11:177-85.
27. Prakash S, Agrawal S, Vahed H, Ngyuen M, BenMohamed L, Gupta S, et al. Dendritic cells from aged subjects contribute to chronic airway inflammation by activating bronchial epithelial cells under steady state. Mucosal Immunol. 2014;7:1386-94.
28. Franceschi C, Bonafè M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine. 2000;18:1717-20.
29. Meyer KC, Ershler W, Rosenthal NS, Lu XG, Peterson K. Immune dysregulation in the aging human lung. Am J Respir Crit Care Med. 1996;153:1072-9.
30. Ho J, Bailey M, Zaunders J, Mrad N, Sacks R, Sewell W, et al. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin Exp Allergy. 2015;45:394-403.
31. Xiao L, Wei Y, Zhang YN, Luo X, Yang BY, Yu SF, et al. Increased IL-21 expression in chronic rhinosinusitis with nasalpolyps. Clin Exp Allergy. 2015;45:404-13.
32. Iinuma T, Okamoto Y, Yamamoto H, Inamine-Sasaki A, Ohki Y, Sakurai T, et al. Interleukin-25 and mucosal T cells in noneosinophilic and eosinophilic chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2015;114:289-98.
33. Hamilos DL. Drivers of chronic rhinosinusitis: Inflammation versus infection. J Allergy Clin Immunol. 2015;136:1454-9.
34. Poposki JA, Peterson S, Welch K, Schleimer RP, Hulse KE, Peters AT, et al. Elevated presence of myeloid dendritic cells in nasal polyps of patients with chronic rhinosinusitis. Clin Exp Allergy. 2015;45:384-93.
35. Kim JH, Kim GE, Cho GS, Kwon HJ, Joo CH, Kim HS, et al. Natural killer cells from patients with chronic rhinosinusitis have impaired effector functions. PLoS One. 2013;8:e77177.
36. Keller S, König V, Mösges R. Thermal water applications in the treatment of upper respiratory tract diseases: a systematic review and meta-analysis. J Allergy. 2014;2014:Article ID 943824.
37. Cristalli G, Abramo A, Pollastrini L. [Treatment of chronic inflammation of the upper respiratory airways by inhalation thermal therapy with sulfur-sulfate-bicarbonate- carbonate-alkaline earth mineral water: a study of nasal cytology]. Acta Otorhinolaryngol Ital. 1996;16 Suppl 55:91-4.
38. Barbieri M, Salami A, Mora F, Casazza A, Sovatzis A, Teglia R, et al. [Behavior of serum IgE and IgA in patients with allergic rhinitis treated with iodine bromide thermal water]. Acta Otorhinolaryngol Ital. 2002;22:215-9.
39. Pellegrini M, Fanin D, Nowicki Y, Guarnieri G, Bordin A, Faggian D, et al. Effect of inhalation of thermal water on airway inflammation in chronic obstructive pulmonary disease. Respir Med. 2005;99:748-54.
40. Lowery EM, Brubaker AL, Kuhlmann E, Kovacs EJ. The aging lung. Clin Interv Aging. 2013;8:1489-96.
41. Heath WR, Carbone FR. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol. 2009;10:1237-44.
42. Wilkinson TM, Li CK, Chui CS, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;18:274-80.
43. Magrone T, Jirillo E. Immunity to tuberculosis and novel therapeutic strategies. Clin Immunol Endocr Metab Drugs. 2014;1:46-60.
44. Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015;15:271-82.
45. Ma LL, O'Byrne PM. The pharmacological modulation of allergen-induced asthma. Inflammopharmacology. 2013;21:113-24.
46. Magrone T, Jirillo E. Intestinal regulatory T cells: their function and modulation by dietary nutrients. Nutr Ther Metab. 2014;32:157-65.
47. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis. 1999;5:285-94.
48. Bogdan C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 2015;36:161-78.
49. May RD, Fung M. Strategies targeting the IL-4/IL-13 axes in disease. Cytokine. 2015;75:89-116.
50. Sarra M, Pallone F, Monteleone G. Interleukin-21 in chronic inflammatory diseases. Biofactors. 2013;39:368-73.
51. Gharibi T, Majidi J, Kazemi T, Dehghanzadeh R, Motallebnezhad M, Babaloo Z. Biological effects of IL-21 on different immune cells and its role in autoimmune diseases. Immunobiology. 2016;221:357-67.
52. Andelid K, Tengvall S, Andersson A, Levänen B, Christenson K, Jirholt P, et al. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization? Int J Chron Obstruct Pulmon Dis. 2015;10:689-702.
53. Man SM, Kanneganti TD. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol. 2016;16:7-21.
54. Magrone T, Jirillo E. Mechanisms of immune responsiveness against influenza virus in lungs and modulation with dietary products. Clin Immunol Endocr Metab Drugs. 2016;3:00.
55. Samuelson DR, Welsh DA, Shellito JE. Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol. 2015;6:1085.
56. Vissers M, de Groot R, Ferwerda G. Severe viral respiratory infections: are bugs bugging? Mucosal Immunol. 2014;7:227-38.
57. Clarke TB. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands. Infect Immun. 2014;82:4596-606.